CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-08-01 | Cormack Scott Daniel Director | Option exercise · Restricted Stock Unit (RSU) | −454 | 0 | ||
| 2017-08-01 | Cormack Scott Daniel Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2017-08-01 | PARKER H STEWART Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2017-08-01 | MATTINGLY MARTIN A Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2017-08-01 | MOYES JAY M Director | Grant or award · Stock Option (right to buy) | +16,400 | 16,400 | ||
| 2017-08-01 | Joseph Donald Director | Grant or award · Stock Option (right to buy) | +16,400 | 16,400 | ||
| 2017-08-01 | Clarke Anthony Chief Scientific Officer | Grant or award | +6,364,335 | 6,364,335 | ||
| 2017-08-01 | Clarke Anthony Chief Scientific Officer | Grant or award | +4,242,890 | 4,242,890 | ||
| 2017-08-01 | Clarke Anthony Chief Scientific Officer | Grant or award | +6,364,335 | 6,364,335 | ||
| 2017-08-01 | Stewart Richard Alistair President & CEO | Grant or award | +22,487,319 | 22,487,319 | ||
| 2017-08-01 | Stewart Richard Alistair President & CEO | Grant or award | +848,578 | 848,578 | ||
| 2017-06-12 | Cormack Scott Daniel President and CEO | Option exercise | +9,375 | 149,425 | ||
| 2017-06-12 | Cormack Scott Daniel President and CEO | Shares withheld for taxes | −4,472 | $0.36 | $2K | 144,953 |
| 2017-06-12 | Cormack Scott Daniel President and CEO | Option exercise | +5,000 | 89,055 | ||
| 2017-06-12 | Cormack Scott Daniel President and CEO | Option exercise · Restricted Stock Unit (RSU) | −9,375 | 9,375 | ||
| 2017-06-12 | Cormack Scott Daniel President and CEO | Option exercise · Restricted Stock Unit (RSU) | −5,000 | 5,000 | ||
| 2017-06-12 | JACOBS CINDY EVP, CMO | Option exercise | +5,000 | 89,359 | ||
| 2017-06-12 | JACOBS CINDY EVP, CMO | Shares withheld for taxes | −1,633 | $0.36 | $588 | 87,726 |
| 2017-06-12 | JACOBS CINDY EVP, CMO | Option exercise · Restricted Stock Unit (RSU) | −5,000 | 5,000 | ||
| 2017-01-10 | JACOBS CINDY EVP, CMO | Option exercise | +10,312 | 87,728 |
Page 20 of 36 · 715 trades